← Back to Clinical Trials
Recruiting NCT05499182

NCT05499182 Latino Teen Depression Treatment Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05499182
Status Recruiting
Phase
Sponsor Duke University
Condition Depression
Study Type OBSERVATIONAL
Enrollment 35 participants
Start Date 2022-10-13
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 35 participants in total. It began in 2022-10-13 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).

Eligibility Criteria

Inclusion Criteria for Teens: * Male gender * Aged 13-17 years * Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder * Referred to psychotherapy and/or prescribed antidepressant medications for depression Exclusion Criteria for Teens: * Experiencing imminent thoughts of self-harm or suicide * Experiencing acute psychological distress (e.g., uncontrolled crying) Inclusion Criteria for Parents: * Parent or legal guardian of teen * Able to read and speak English or Spanish Exclusion Criteria for Parents: * Unable to read/speak English or Spanish Inclusion Criteria for Healthcare Providers: * Self-identification as regularly providing clinical care to Latino adolescents with depression * Be in a role in which they can provide or refer patients to depression treatment Exclusion Criteria for Healthcare Providers * Unable to provide or refer to depression treatment

Contact & Investigator

Central Contact

Allison M Stafford, PhD

✉ allison.stafford@duke.edu

📞 (317) 498-7333

Principal Investigator

Allison M Stafford, PhD

PRINCIPAL INVESTIGATOR

Duke University School of Nursing

Frequently Asked Questions

Who can join the NCT05499182 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05499182 currently recruiting?

Yes, NCT05499182 is actively recruiting participants. Contact the research team at allison.stafford@duke.edu for enrollment information.

Where is the NCT05499182 trial being conducted?

This trial is being conducted at Nashville, United States.

Who is sponsoring the NCT05499182 clinical trial?

NCT05499182 is sponsored by Duke University. The principal investigator is Allison M Stafford, PhD at Duke University School of Nursing. The trial plans to enroll 35 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology